Lung ultrasound (LUS) may be an effective screening tool for interstitial lung disease in patients with asymptomatic rheumatoid arthritis.

The prescribing information for Abrysvo ® (respiratory syncytial virus [RSV] vaccine) and Arexvy ® (RSV vaccine, adjuvanted) has been updated to include a new warning regarding the risk of ...

The CDC ACIP recommends 2 doses of the 2024-2025 COVID-19 vaccine for those age 65+ years and 2 or more doses for immunocompromised individuals.

The FDA is reviewing new vaccines for meningitis and chikungunya and therapies for Parkinson disease and PTSD.

One in four older US veterans report being diagnosed with cardiovascular disease in their lifetime, according to study findings.

Extended-course nirmatrelvir/ritonavir yields a meaningful reduction in symptoms for some patients with long COVID, but not all benefits persist.

A gap persists between the need for and receipt of substance use disorder treatment among United States individuals.

Exercise PH — measured by the mPAP/CO slope — may predict survival in patients with normal or mildly elevated pulmonary arterial pressure.

Two pulmonologists were sued for malpractice but not held liable after failing to detect liver cancer in a patient being treated for cough.

Lanadelumab has been found to be effective as long-term prophylaxis in reducing attack frequency in patients with HAE.

Neighborhood socioeconomic deprivation is independently linked to worse follow-up adherence for incidentally found pulmonary nodules.

Cuts to Medicare physician reimbursement have taken effect, as proposed legislation intended to eliminate those cuts did not pass.